North America Analysis
Home Search

cannabis - search results

If you're not happy with the results, please do another search
brain effects

Cannabis oil: A preliminary study for the evaluation of brain effects

Here, content director Joseph at TheAmsterdam.com, discusses the effects of cannabidiol on the brain.
Access to medical cannabis

Access to medical cannabis and to what extent is medical cannabis now legalised?

Cosmo Feilding Mellen, Managing Director of Spectrum Therapeutics UK looks at access to medical cannabis and to what extent is medical cannabis now legalised.
medicinal cannabis company

MariPharm: The world’s first medicinal cannabis company

Here, General Manager Bart den Hertog, introduces MariPharm, the world’s first medicinal cannabis business, highlighting the company’s major milestone moments, its clinical trial process and recommended product dosage.
academy of medical cannabis

The Academy of Medical Cannabis

Professor Mike Barnes, Director of Education at The Academy of Medical Cannabis shares his thoughts on the rescheduling of cannabis to a Schedule II substance in November of 2018 and access to medical cannabis prescriptions.
industrial hemp

Industrial hemp: Part of the cannabis sativa family

Henri Sant-Cassia from CBD Virtue turns the spotlight onto industrial hemp, a part of the cannabis sativa family.
medical cannabis industry

Regulation and quality control for the medical cannabis industry

AlphaCAT (Cannabinoid Analysis Test) takes the first step to regulation and quality control for the medical cannabis industry, as this profile by the firm’s Sebastien Beguerie sheds light on.
Caleb McMillian

Caleb McMillian – Cannabis Life Network

Caleb McMillian, Staff Writer at Cannabis Life Network,  focuses on the political economy of the cannabis industry.
sativa and indica

Is there a difference between Sativa and Indica cannabis?

Cannabis patient, budtender and growers assistant, Caleb McMillan, ponders if there is a difference between Sativa and Indica cannabis.
standards for cannabis

Europe setting standards for cannabis products

As government authorities come to grips with legislation of cannabis-based products, the European market holds a key position, Liam McGreevy, CEO, Ethnopharm Ltd explains.
cannabis products, European Monitoring Centre for Drugs and Drug Addiction

Cannabis products: Greater diversity, increased potency and close monitoring

A recent European Monitoring Centre for Drugs and Drug Addiction report highlights the need for diversity of cannabis products, increased potency and close monitoring of health effects.
workplace mental health

The cannabis industry in the UK: Risky business?

Is the cannabis industry in the UK a risky business? John Binns, Partner at BCL Solicitors LLP finds out more.
cannabis analysis

Fundación CANNA: Promoting research, scientific studies and cannabis analysis

Here, we find out about Fundación CANNA’s aim is to promote research and education about cannabis, including their strong focus on the effects of this on the human body.
medical cannabis access

UK and Ireland medical cannabis access programmes and education slowly progress

GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.
medical cannabis farms, bord na mona

Irish bogs could be transformed into medical cannabis farms

The Minister for Health continues to tackle the issue of access to medical cannabis, unemployment and sustainable energy via the idea of peat bogs as medical cannabis farms.
cannabis report

Mile High Labs welcomes findings from cannabis report

Mile High Labs has announced support for the findings in a Centre for Medicinal Cannabis report.
medicinal benefits of CBD

The medicinal benefits of CBD oil and medical cannabis

Here we provide a brief introduction to the medical benefits of CBD and medical Cannabis, with an overview of treatments that have been implemented.
medical cannabis products

Five-year license issued to “Pharma Essenza Cannabis SA” and “PENTE SA”

A five-year license has been issued to two companies allowing the cultivation and processing of medical cannabis products.
access to medical cannabis, medical drug

We need to talk about access to medical cannabis

Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
Marijuana use

Marijuana use during pregnancy: The cannabis conundrum

Dennis R. Carty, Ph.D. and Pamela J. Lein, Ph.D., University of California, highlight the rising trend of marijuana use during pregnancy and the implications surrounding it.
medicinal cannabis, clinical research, educational support, educate clinicians

Medicinal cannabis requires further clinical research and educational support

Dr Mark Ware, Chief Medical Officer at Canopy Growth, provides an overview of the research that already exists around medicinal cannabis and explains why there is a need to educate clinicians further.

Follow Open Access Government